Mikhail Roshal
Overview
Explore the profile of Mikhail Roshal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
3591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roshal M, Gao Q
Am J Clin Pathol
. 2025 Feb;
PMID: 39921543
Objective: Detection of minimal/measurable disease (MRD) in acute myeloid leukemia (AML) is critical for both clinical decision-making and prognostication, yet remains a challenge. Flow cytometry is a well-established method for...
2.
El Daker S, Qualls D, Derkach A, Beqaj S, Boiocchi L, Seshan V, et al.
Haematologica
. 2025 Feb;
PMID: 39911114
Follicular lymphoma (FL) is an indolent B cell lymphoma with a heterogenous disease course, and patients may not require immediate treatment upon diagnosis. Scrutiny of its microenvironment may provide key...
3.
Galera P, Dilip D, Derkach A, Chan A, Zhang Y, Persaud S, et al.
Blood
. 2025 Jan;
PMID: 39813682
A mixed phenotype is characteristic of de novo Mixed Phenotype Acute Leukemia (MPAL) but can also be seen in other leukemias. It poses substantial classification and management dilemmas. Herein, we...
4.
5.
Lewis N, Petrova-Drus K, Sardana R, Huet S, Gao Q, Sethi S, et al.
Haematologica
. 2024 Jul;
110(2):475-480.
PMID: 39021226
No abstract available.
6.
Falchi L, Rahman J, Melendez L, Douglas M, Amador W, Hamlin P, et al.
medRxiv
. 2024 Jul;
PMID: 39006439
Leveraging endogenous tumor-resident T-cells for immunotherapy using bispecific antibodies (BsAb) targeting CD20 and CD3 has emerged as a promising therapeutic strategy for patients with B-cell non-Hodgkin lymphomas. However, features associated...
7.
Pourmaleki M, Jones C, Mellinghoff S, Greenstein B, Kumar P, Foronda M, et al.
Clin Cancer Res
. 2024 Jul;
30(17):3881-3893.
PMID: 38949890
Purpose: Classic Hodgkin lymphoma (cHL) is a B-cell lymphoma that occurs primarily in young adults and, less frequently, in elderly individuals. A hallmark of cHL is the exceptional scarcity (1%-5%)...
8.
Aypar U, Dilip D, Gadde R, Londono D, Liu Y, Gao Q, et al.
Histopathology
. 2024 Apr;
85(2):310-316.
PMID: 38686611
Aims: B lymphoblastic leukaemia/lymphoma (B-ALL) is thought to originate from Pro/Pre-B cells and the genetic aberrations largely reside in lymphoid-committed cells. A recent study demonstrated that a proportion of paediatric...
9.
Kumar J, Lewis N, Sherpa S, Londono D, Sun X, Gao Q, et al.
Haematologica
. 2024 Apr;
109(8):2676-2681.
PMID: 38572547
No abstract available.
10.
Krystel-Whittemore M, Petrova-Drus K, Ptashkin R, Ewalt M, Yao J, Liu Y, et al.
Haematologica
. 2024 Mar;
109(10):3269-3281.
PMID: 38450530
Comprehensive genomic sequencing is becoming a critical component in the assessment of hematologic malignancies, with broad implications for patients' management. In this context, unequivocally discriminating somatic from germline events is...